Ada Investment Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Ada Investment Management’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$211K	Buy	+3,927	New	+$198K	0.14%	317

Other funds holding ITCI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ada Investment Management's ITCI Position: Q4 2015 in Review

Ada Investment Management opened a new position in Intra-Cellular Therapies Inc. (ITCI) in Q4 2015: 3,927 shares worth $211K. The stake represents 0.14% of the portfolio and ranks #317 among its holdings.

132 funds tracked by Wall St. Rank hold ITCI as of Q4 2015.

Ada Investment Management held 3,927 shares of Intra-Cellular Therapies Inc. worth $211K as of Q4 2015.
Intra-Cellular Therapies Inc. was a new Ada Investment Management position in Q4 2015.
Intra-Cellular Therapies Inc. made up 0.14% of Ada Investment Management's portfolio in Q4 2015, its #317 holding.
132 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2015.

Based on Ada Investment Management's 13F filing for Q4 2015, filed 19 Feb 2016.